26Rfa, Hypothalamic Peptide, human

26Rfa, Hypothalamic Peptide, human is a biologically active neuropeptide that belongs to the RFamide peptide family and is predominantly expressed in the hypothalamus. Structurally characterized by its conserved C-terminal Arg-Phe-NH2 motif, this peptide plays a significant role in the regulation of energy homeostasis, feeding behavior, and neuroendocrine signaling in humans. Its discovery has provided new insights into the complex mechanisms governing appetite control, metabolic regulation, and neuropeptide signaling pathways. As an important modulator within central nervous system circuits, 26Rfa is a valuable tool for researchers investigating neuropeptide function, receptor interactions, and the intricate networks underlying hypothalamic regulation.

Neuropeptide Signaling Research: 26Rfa is widely utilized in studies aimed at elucidating the mechanisms of neuropeptide signaling within the hypothalamus and other brain regions. Researchers employ this peptide to investigate its binding affinity and activation of G protein-coupled receptors, particularly the GPR103 receptor, which mediates many of its physiological effects. By applying 26Rfa in in vitro and in vivo experimental models, scientists can dissect downstream signaling cascades, receptor-ligand specificity, and the broader implications of RFamide peptides in neural communication.

Appetite and Energy Balance Studies: The peptide is a critical reagent for exploring the central regulation of appetite and energy expenditure. Experimental administration in animal models or cell-based assays allows for the assessment of its orexigenic (appetite-stimulating) properties and its influence on feeding behavior. Researchers leverage these properties to better understand the neurobiological substrates of hunger, satiety, and metabolic disorders, providing a foundation for the development of new hypotheses related to obesity and energy homeostasis.

Neuroendocrine Function Analysis: 26Rfa serves as a functional probe for examining neuroendocrine pathways that link the central nervous system to peripheral endocrine organs. Its modulatory effects on the secretion of hormones such as growth hormone and prolactin are of particular interest in studies investigating hypothalamic-pituitary axis regulation. Utilizing this peptide enables the dissection of feedback mechanisms, hormonal rhythms, and the integration of neural and endocrine signals in physiological and pathophysiological contexts.

Peptide-Receptor Interaction Studies: As a well-characterized ligand for the GPR103 receptor, 26Rfa is instrumental in receptor pharmacology research. Scientists employ it to characterize receptor binding kinetics, signal transduction efficacy, and structure-activity relationships. These studies not only enhance understanding of RFamide receptor biology but also support the identification and validation of novel modulators or antagonists for experimental applications.

Peptide Functional Assays: The use of 26Rfa extends to a variety of functional assays designed to measure peptide-induced cellular responses, including calcium mobilization, cAMP accumulation, and downstream gene expression changes. These assays facilitate high-resolution analysis of peptide activity in neuronal and non-neuronal cell lines, supporting the development of robust experimental systems for screening and mechanistic studies. By integrating this peptide into functional assays, researchers can elucidate its role in cellular signaling networks and expand the toolkit available for neurobiological investigation.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. Cationic cell-penetrating peptides are potent furin inhibitors